Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
National
Emily Atkinson

BIZARRE: New obesity jab that sparked diabetes row in us could get nhs green light - What They Never Told You

Getty

A new obesity jab that sparked a diabetes row in the US is now being considered for wider use by the UK health service.

Tirzepatide, from Eli Lilly and Company, is currently approved by regulators for type 2 diabetes – but may soon also be approved to treat obesity.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.